Seamlessly Transition from Microarray to NGS

Next-Generation Sequencing (NGS) unlocks a level of resolution and flexibility previously out of reach. At Gene by Gene, we provide the laboratory expertise for scaling with our NGS-based solutions offering superior data density and discovery power.

Gene by Gene Is Offering Special Pilot Rates for Partners Who Qualify
If you are actively planning a transition from Arrays to NGS, Gene by Gene is offering special pilot rates for partners who qualify. We will contact to to understand your business and how we can best help you now or in the future, please fill out the form below.

Arrays to NGS

Fill out this intake form to schedule a meeting with Gene by Gene to discuss your project needs.

Intake Form

Why Move to NGS?

Microarrays are limited to predefined content. NGS allows you to discover novel variants, identify rare mutations, and customize your focus without the constraints of
a physical chip.

  • Pricing Accessibility: Pricing for sequencing has dropped. 
  • Higher Resolution: Detect SNPs, indels, and structural variants in a single assay.
  • Unbiased Discovery: Stop looking only for what you know; see everything the genome has to offer.
  • Scalable Economics: With our high-capacity sequencing suites, the cost-per-datapoint is now competitive with high-density arrays.

Ready to take the next step?

Partner with Gene by Gene to transition your workflows to the most advanced sequencing platform available. 

Arrays to NGS

Fill out this intake form to schedule a meeting with
Gene by Gene to discuss your project needs.

Intake Form

For more information, please view the GenomeWeb webinar 

Speaker lineup:
Arjan Bormans | CSO | Gene by Gene
Florian Oberstrass | SVP Technology Dev | Ultima Genomics
Jonathan Soohoo | Staff Product Manager | Twist Bioscience

Watch Webinar

Learn more about Whole Genome Sequencing

A scientist pipetting in a lab
Whole Genome Sequencing (WGS)

Whole Genome Sequencing (WGS) is rapidly becoming more affordable, and is a powerful tool to identify inherited disorders and mutations that drive cancer progression or for tracking disease risk.

Learn More >